$ Value
$0
Shares
150,000
Price
$0
Filed
Jul 3
Insider
Name
Funtleyder Leslie D.
Title
Chief Financial Officer
CIK
0001775394
Roles
Transaction Details
Transaction Date
2025-06-09
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
787,121
Footnotes
Consists of compensatory Restricted Stock Units ("RSUs") granted under the Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan (the "Plan"). Each compensatory RSU represents a contingent right to receive one share of the Issuer's common stock. The compensatory RSUs shall vest in equal monthly installments over the twenty-four month period immediately following April 1, 2025, subject to the Reporting Person continuing to provide services through each such date. | The total holdings have been adjusted to correct an administrative error in prior Form 4s that resulted in the overstatement of the total holdings. | Consists of compensatory RSUs granted under the Plan. Each compensatory RSU represents a contingent right to receive one share of the Issuer's common stock. The compensatory RSUs shall vest in equal monthly installments over the twenty-four month period immediately following July 1, 2025, subject to the Reporting Person continuing to provide services through each such date.
Filing Info
Funtleyder Leslie D.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-03 | APLT | D | — |
| 2026-02-03 | APLT | U | — |
| 2026-02-03 | APLT | D | — |
| 2026-02-03 | APLT | D | — |
| 2026-02-03 | APLT | D | — |
| 2026-02-03 | APLT | D | — |
| 2026-02-03 | APLT | D | — |
| 2026-02-03 | APLT | D | — |
| 2026-01-01 | APLT | A | $0 |
| 2025-12-19 | APLT | A | $0 |
Other Insiders at APLT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| SKYLER JAY S | — | — | 2026-02-03 |
|
Hooks Corwin Dale
Chief Commercial Officer
|
— | — | 2026-02-03 |
|
Funtleyder Leslie D.
Chief Financial Officer
|
— | — | 2026-02-03 |
| Lerner Teena | — | — | 2026-02-03 |
| Kanter Stacy J. | — | — | 2026-02-03 |
|
Chinoporos Constantine
See Remarks
|
— | — | 2026-02-03 |
|
Bailey Evan Prescott
Chief Medical Officer
|
— | — | 2026-02-03 |